KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Other Non-Current Liabilities (2016 - 2025)

Quest Diagnostics' Other Non-Current Liabilities history spans 17 years, with the latest figure at $957.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 2.03% year-over-year to $957.0 million; the TTM value through Dec 2025 reached $957.0 million, up 2.03%, while the annual FY2025 figure was $957.0 million, 2.03% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $957.0 million at Quest Diagnostics, down from $982.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $982.0 million in Q3 2025 and bottomed at $6.0 million in Q2 2024.
  • The 5-year median for Other Non-Current Liabilities is $814.5 million (2022), against an average of $767.0 million.
  • The largest annual shift saw Other Non-Current Liabilities plummeted 93.18% in 2024 before it skyrocketed 14733.33% in 2025.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $792.0 million in 2021, then rose by 2.53% to $812.0 million in 2022, then grew by 7.88% to $876.0 million in 2023, then rose by 7.08% to $938.0 million in 2024, then increased by 2.03% to $957.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Other Non-Current Liabilities are $957.0 million (Q4 2025), $982.0 million (Q3 2025), and $890.0 million (Q2 2025).